The association of maximum body weight on the development of type 2 diabetes and microvascular complications: MAXWEL study

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Lim, Soo ^a,d,e   Kim, Kyoung Min ^a   Kim, Min Joo ^b   Woo, Se Joon ^a   Choi, Sung Hee ^a   Park, Kyong Soo ^c   Jang, Hak Chul ^a   Meigs, James B ^d,e   Wexler, Deborah J ^d,e  

^a Seoul National University Bundang Hospital   (South Korea)

^b Korea Cancer Center Hospital   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d HARVARD MEDICAL SCHOOL   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; LIPID;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; COHORT ANALYSIS; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; FAMILY HISTORY; FEMALE; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; RISK REDUCTION; SEX; WEIGHT GAIN;

ADULT; AGED; ALBUMINURIA; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHT; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; RISK FACTORS;

EID: 84891890207     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080525     Document Type: Article

References (33)

1. Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87: 4-14.
2. Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, et al. (2010) Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 87: 293-301.
3. Field AE, Coakley EH, Must A, Spadano JL, Laird N, et al. (2001) Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 161: 1581-6.
4. Olefsky JM, Kolterman OG, Scarlett JA (1982) Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am J Physiol 243: E15-E30.
5. Ford ES, Williamson DF, Liu S (1997) Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol 146: 214-22.
6. Hanson RL, Narayan KM, McCance DR, Pettitt DJ, Jacobsson LT, et al. (1995) Rate of weight gain, weight fluctuation, and incidence of NIDDM. Diabetes 44: 261-6.
7. Wannamethee SG, Shaper AG (1999) Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care 22: 1266-72.
8. Wannamethee SG, Shaper AG, Walker M (2005) Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes. J Epidemiol Community Health 59: 134-9.
9. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393-403.
10. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344: 1343-50.
11. Li G, Zhang P, Wang J, Gregg EW, Yang W, et al. (2008) The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371: 1783-9.
12. (2012) Diagnosis and classification of diabetes mellitus. Diabetes Care 35 Suppl 1: S64-S71.
13. Wilkinson CP, Ferris FL, III, Klein RE, Lee PP, Agardh CD, et al. (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110: 1677-82.
14. Resnick HE, Valsania P, Halter JB, Lin X (2000) Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults. J Epidemiol Community Health 54: 596-602.
15. Looker HC, Knowler WC, Hanson RL (2001) Changes in BMI and weight before and after the development of type 2 diabetes. Diabetes Care 24: 1917-22.
16. Oguma Y, Sesso HD, Paffenbarger RS, Jr., Lee IM (2005) Weight change and risk of developing type 2 diabetes. Obes Res 13: 945-51.
17. Koh-Banerjee P, Wang Y, Hu FB, Spiegelman D, Willett WC, et al. (2004) Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. Am J Epidemiol 159: 1150-9.
18. Brancati FL, Wang NY, Mead LA, Liang KY, Klag MJ (1999) Body weight patterns from 20 to 49 years of age and subsequent risk for diabetes mellitus: the Johns Hopkins Precursors Study. Arch Intern Med 159: 957-63.
19. McCance DR, Pettitt DJ, Hanson RL, Jacobsson LT, Bennett PH, et al. (1994) Glucose, insulin concentrations and obesity in childhood and adolescence as predictors of NIDDM. Diabetologia 37: 617-23.
20. Szoke E, Shrayyef MZ, Messing S, Woerle HJ, van Haeften TW, et al. (2008) Effect of aging on glucose homeostasis: accelerated deterioration of beta-cell function in individuals with impaired glucose tolerance. Diabetes Care 31: 539-43.
21. Chiu KC, Lee NP, Cohan P, Chuang LM (2000) Beta cell function declines with age in glucose tolerant Caucasians. Clin Endocrinol (Oxf) 53: 569-75.
22. Black E, Holst C, Astrup A, Toubro S, Echwald S, et al. (2005) Long-term influences of body-weight changes, independent of the attained weight, on risk of impaired glucose tolerance and Type 2 diabetes. Diabet Med 22: 1199-205.
23. Thearle MS, Bunt JC, Knowler WC, Krakoff J (2009) Childhood predictors of adult acute insulin response and insulin action. Diabetes Care 32: 938-43.
24. Lingohr MK, Buettner R, Rhodes CJ (2002) Pancreatic beta-cell growth and survival-a role in obesity-linked type 2 diabetes? Trends Mol Med 8: 375-84.
25. Truesdale KP, Stevens J, Cai J (2005) The effect of weight history on glucose and lipids: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 161: 1133-43.
26. Rhee EJ, Choi JH, Yoo SH, Bae JC, Kim WJ, et al. (2011) The association of unintentional changes in weight, body composition, and homeostasis model assessment index with glycemic progression in non-diabetic healthy subjects. Diabetes Metab J 35: 138-48.
27. Chalmers L, Kaskel FJ, Bamgbola O (2006) The role of obesity and its bioclinical correlates in the progression of chronic kidney disease. Adv Chronic Kidney Dis 13: 352-64.
28. Rutledge JC, Ng KF, Aung HH, Wilson DW (2010) Role of triglyceride-rich lipoproteins in diabetic nephropathy. Nat Rev Nephrol 6: 361-70.
29. Dirani M, Xie J, Fenwick E, Benarous R, Rees G, et al. (2011) Are obesity and anthropometry risk factors for diabetic retinopathy? The diabetes management project. Invest Ophthalmol Vis Sci 52: 4416-21.
30. Ezzati M, Martin H, Skjold S, Vander HS, Murray CJ (2006) Trends in national and state-level obesity in the USA after correction for self-report bias: analysis of health surveys. J R Soc Med 99: 250-7.
31. McAdams MA, van Dam RM, Hu FB (2007) Comparison of self-reported and measured BMI as correlates of disease markers in US adults. Obesity (Silver Spring) 15: 188-96.
32. Waring ME, Eaton CB, Lasater TM, Lapane KL (2010) Incident diabetes in relation to weight patterns during middle age. Am J Epidemiol 171: 550-6.
33. Field AE, Manson JE, Laird N, Williamson DF, Willett WC, et al. (2004) Weight cycling and the risk of developing type 2 diabetes among adult women in the United States. Obes Res 12: 267-74.